Recommendations developed for preventive care in cirrhosis

Clinical guidelines published in the American Journal of Gastroenterology on October 5 recommend preventive care measures for patients with cirrhosis. These recommendations, developed by Elliot B. Tapper and colleagues at the University of Michigan, encompass 18 recommendations and six key concepts across various domains. The most strongly advised interventions include the use of carvedilol or variceal ligation for high-risk esophageal varices, semiannual surveillance for hepatocellular carcinoma, and vaccination against hepatitis A and B. Other preventive measures include influenza, severe acute respiratory syndrome coronavirus 2, and respiratory syncytial virus vaccinations, as well as counseling for smoking cessation.

For patients experiencing minimal hepatic encephalopathy, lactulose and rifaximin are suggested as adjunctive treatments. In cases of upper gastrointestinal bleeding, short-course antibiotics via prophylaxis are recommended, along with behavioral therapy for alcohol use disorder after discharge. The guidelines also advocate for dietitian-guided nutrition, structured exercise, and the use of bisphosphonates to manage osteoporosis in cirrhosis patients.

However, the evidence supporting these recommendations is predominantly of low certainty, indicating the need for a comprehensive and multifaceted implementation strategy across different clinical settings.